Stock ZICC ZICCUM AB
Add to a list
To use this feature you must be a member
Log inSign up

All News Ziccum AB

Equities

ZICC

SE0011415595

Market Closed - Nasdaq Stockholm
Other stock markets
 16:29:47 21/05/2024 BST 		5-day change 1st Jan Change
6 SEK +2.04% Intraday chart for Ziccum AB -2.28% -21.67%
04-29 Ziccum AB Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
03-14 Ziccum AB Inhalable mRNA/LNP Project Confirms Excellent Properties Obtained by LaminarPace CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Ziccum CEO Analyst video interview: Q1, 2024 highlights
AQ
Ziccum AB strengthens patent portfolio with three solid data PCT applications according to expanded IP strategy
AQ
Ziccum AB (publ) Interim report Q1 2024
AQ
Ziccum AB Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Ziccum contracts RFR Solutions for GMP manufacturing in next phase of technology scale-out
AQ
Ziccum AB (publ) releases Annual Report 2023
AQ
Ziccum CEO to present at first annual event for Biopharma/Biotech disruptors hosted by major US bank in New York City
AQ
Ziccum strengthens and streamlines business and finance functions
AQ
Ziccum inhalable mRNA/LNP project confirms excellent properties obtained by LaminarPace
AQ
Ziccum AB Inhalable mRNA/LNP Project Confirms Excellent Properties Obtained by LaminarPace
CI
Ziccum reports significant progress in 3D-modelling project with model completion
AQ
Ziccum AB and project partner Zurich institute of Applied Sciences Updates LaminarPace Simulation Project Progress and Findings
CI
Ziccum announces last day of trading in BTU
AQ
Ziccum announces outcome in rights issue
AQ
Ziccums CEO Ann Gidner in Fireside Chat on mRNA development hosted by US Force Family Office
AQ
Last day for trading in unit rights in Ziccum
AQ
Ziccum's Board of Directors and Management Group use all their Unit Rights in the ongoing new share issue.
AQ
Ziccum CEO video interview: mRNA in focus
AQ
Join Ziccum CEO Ann Gidner for ‘Invest Live’, a live digital presentation and Q&A, Tues Feb 6th
AQ
Ziccum has proven excellent mRNA activity in animal study with LaminarPace material
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ZICC Stock
  4. News Ziccum AB